Oral SERD Trial Setback: Roche's Giredestrant Results
Kilder
- Nature: Microbiome modulation in cancer immunotherapy - Nature
- Nature: Logic‑gated nanomedicine activates STING to boost metastatic tumour immunotherapy - Nature
- Nature: Restoration of RBM22 overcomes the transcriptional and epigenetic barriers of cardiomyocyte proliferation for heart regeneration - Nature
- Nature: Nature-inspired confined cascade enzyme nanoreactors for targeted atherosclerosis therapy - Nature
- Nature: Bioengineered ferritin-based lysosome-targeting chimera platform for tumor-targeted therapy - Nature
- Fiercebiotech: Roche's oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits - Fierce Biotech
- wikimedia: Photo by Иоанна Чернова / Wikimedia Commons / CC BY 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.